Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth.

Li, Xi

Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. [electronic resource] - Cancer gene therapy Feb 2003 - 105-11 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0929-1903

10.1038/sj.cgt.7700530 doi


Angiogenesis Inhibitors--administration & dosage
Animals
Anti-Bacterial Agents--pharmacology
Apoptosis--genetics
Bifidobacterium--drug effects
Cell Division--drug effects
Cell Hypoxia
Collagen--administration & dosage
Drug Delivery Systems
Drug Resistance, Bacterial--genetics
Endostatins
Gene Expression
Genetic Therapy--methods
Liver Neoplasms, Experimental--microbiology
Male
Mice
Mice, Inbred BALB C
Peptide Fragments--administration & dosage
Plasmids--genetics
Polymerase Chain Reaction--methods